@article {1507,
	title = {Cost-effectiveness of preventing loss to follow-up in HIV treatment programs: a C{\^o}te d{\textquoteright}Ivoire appraisal.},
	journal = {PLoS medicine},
	volume = {6},
	year = {2009},
	month = {2009 Oct},
	pages = {e1000173},
	abstract = {Data from HIV treatment programs in resource-limited settings show extensive rates of loss to follow-up (LTFU) ranging from 5\% to 40\% within 6 mo of antiretroviral therapy (ART) initiation. Our objective was to project the clinical impact and cost-effectiveness of interventions to prevent LTFU from HIV care in West Africa.},
	keywords = {Anti-HIV Agents, Antiretroviral Therapy, Highly Active, Cost-Benefit Analysis, Cote d{\textquoteright}Ivoire, Developing Countries, Follow-Up Studies, Health Care Costs, HIV Infections, Humans, Life Expectancy, Treatment Outcome},
	issn = {1549-1676},
	doi = {10.1371/journal.pmed.1000173},
	author = {Losina, Elena and Tour{\'e}, Hapsatou and Uhler, Lauren M and Anglaret, Xavier and Paltiel, A David and Balestre, Eric and Walensky, Rochelle P and Messou, Eug{\`e}ne and Weinstein, Milton C and Dabis, Fran{\c c}ois and Freedberg, Kenneth A}
}
